טוען...
Effective Crizotinib schedule for an elderly patient with ALK rearranged non-small-cell lung cancer: a case report
BACKGROUND: Non-small-cell lung cancers (NSCLCs) harboring translocations in anaplastic lymphoma kinase (ALK) are highly sensitive to small-molecule ALK kinase inhibitors, such as crizotinib. CASE PRESENTATION: We describe a case of post-operative local recurrence of lung adenocarcinoma in an 81 yea...
שמור ב:
| הוצא לאור ב: | BMC Res Notes |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4415237/ https://ncbi.nlm.nih.gov/pubmed/25899913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-015-1126-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|